Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

The rs10993994 Risk Allele for Prostate Cancer Results in Clinically Relevant Changes in Microseminoprotein-Beta Expression in Tissue and Urine

  • Hayley C. Whitaker ,

    Hayley.Whitaker@cancer.org.uk

    Affiliation Uro-Oncology Research Group, CRUK Cambridge Research Institute, Cambridge, United Kingdom

  • Zsofia Kote-Jarai ,

    Contributed equally to this work with: Zsofia Kote-Jarai, Helen Ross-Adams

    Affiliations The Institute of Cancer Research, Sutton, Surrey, United Kingdom, Royal Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom

  • Helen Ross-Adams ,

    Contributed equally to this work with: Zsofia Kote-Jarai, Helen Ross-Adams

    Affiliation Uro-Oncology Research Group, CRUK Cambridge Research Institute, Cambridge, United Kingdom

  • Anne Y. Warren,

    Affiliation Department of Pathology, Addenbrookes Hospital, Cambridge, United Kingdom

  • Johanna Burge,

    Affiliation Uro-Oncology Research Group, CRUK Cambridge Research Institute, Cambridge, United Kingdom

  • Anne George,

    Affiliation Uro-Oncology Research Group, CRUK Cambridge Research Institute, Cambridge, United Kingdom

  • Elizabeth Bancroft,

    Affiliations The Institute of Cancer Research, Sutton, Surrey, United Kingdom, Royal Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom

  • Sameer Jhavar,

    Affiliations The Institute of Cancer Research, Sutton, Surrey, United Kingdom, Royal Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom

  • Daniel Leongamornlert,

    Affiliations The Institute of Cancer Research, Sutton, Surrey, United Kingdom, Royal Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom

  • Malgorzata Tymrakiewicz,

    Affiliations The Institute of Cancer Research, Sutton, Surrey, United Kingdom, Royal Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom

  • Edward Saunders,

    Affiliations The Institute of Cancer Research, Sutton, Surrey, United Kingdom, Royal Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom

  • Elizabeth Page,

    Affiliations The Institute of Cancer Research, Sutton, Surrey, United Kingdom, Royal Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom

  • Anita Mitra,

    Affiliations The Institute of Cancer Research, Sutton, Surrey, United Kingdom, Royal Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom

  • Gillian Mitchell,

    Affiliation Peter Maccallum Cancer Centre, Victoria, Australia

  • Geoffrey J. Lindeman,

    Affiliation The Royal Melbourne Hospital and The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia

  • D. Gareth Evans,

    Affiliation Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, United Kingdom

  • Ignacio Blanco,

    Affiliation Catalonian Institute of Oncology, L'Hospitalet, Barcelona, Spain

  • Catherine Mercer,

    Affiliation Wessex Clinical Genetics Service, The Princess Anne Hospital, Southampton, United Kingdom

  • Wendy S. Rubinstein,

    Affiliation NorthShore University Health System, Evanston, Illinois, United States of America

  • Virginia Clowes,

    Affiliation Department of Clinical Genetics, Addenbrookes Hospital, Cambridge, United Kingdom

  • Fiona Douglas,

    Affiliation Institute of Human Genetics, Newcastle-Upon-Tyne, United Kingdom

  • Shirley Hodgson,

    Affiliation St George's, University of London, London, United Kingdom

  • Lisa Walker,

    Affiliation Oxford Regional Genetics Centre, Churchill Hospital, Oxford, United Kingdom

  • Alan Donaldson,

    Affiliation St Michael's Hospital, Bristol, United Kingdom

  • Louise Izatt,

    Affiliation Guy's Hospital, London, United Kingdom

  • Huw Dorkins,

    Affiliation Kennedy Galton Centre, Northwick Park Hospital, Harrow, Middlesex, United Kingdom

  • Alison Male,

    Affiliation Institute of Child Health, London, United Kingdom

  • Kathy Tucker,

    Affiliation Prince of Wales Hospital, Sydney, New South Wales, Australia

  • Alan Stapleton,

    Affiliation Repatriation General Hospital, Adelaide, Australia

  • Jimmy Lam,

    Affiliation Repatriation General Hospital, Adelaide, Australia

  • Judy Kirk,

    Affiliation Familial Cancer Service, Westmead Hospital, Westmead, New South Wales, Australia

  • Hans Lilja,

    Affiliation Departments of Clinical Laboratories, Surgery, Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America

  • Douglas Easton,

    Affiliation Cancer Research UK Genetic Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom

  • The IMPACT Study Steering Committee ,

    List of The IMPACT Study Steering Committee available on request.

  • The IMPACT Study Collaborators ,

    List of The IMPACT Study Collaborators available on request.

  • UK GPCS Collaborators ,

    List of UK GPCS Collaborators available on request.

  • Colin Cooper,

    Affiliations The Institute of Cancer Research, Sutton, Surrey, United Kingdom, Royal Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom

  • Rosalind Eeles,

    Affiliations The Institute of Cancer Research, Sutton, Surrey, United Kingdom, Royal Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom

  •  [ ... ],
  • David E. Neal

    Affiliation Uro-Oncology Research Group, CRUK Cambridge Research Institute, Cambridge, United Kingdom

  • [ view all ]
  • [ view less ]

Viewed

Cited

Saved

Discussed

Powered by Altmetric
Questions or concerns about usage data? Please let us know.